Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity

ClinicalTrials.gov ID: NCT04969939

Public ClinicalTrials.gov record NCT04969939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Investigation of Efficacy and Safety of NNC0165-1875 as add-on to Semaglutide for Weight Management in Subjects With Obesity

Study identification

NCT ID
NCT04969939
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
120 participants

Conditions and interventions

Conditions

Interventions

  • Semaglutide 2.4 mg and NNC0165-1875 1.0 mg Drug
  • Semaglutide 2.4 mg and NNC0165-1875 2.0 mg Drug
  • Semaglutide 2.4 mg and placebo 1.0 mg Drug
  • Semaglutide 2.4 mg and placebo 2.0 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 14, 2021
Primary completion
Dec 5, 2022
Completion
Jan 29, 2023
Last update posted
Jan 7, 2026

2021 – 2023

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Univ of Alabama Birmingham Birmingham Alabama 35294
Anaheim Clinical Trials, LLC Anaheim California 92801
Profil Institute For Clinical Research Inc Chula Vista California 91911
Velocity Clin Res Los Angeles Los Angeles California 90017
Diablo Clinical Research, Inc. Walnut Creek California 94598
Jacksonville Ctr For Clin Res Jacksonville Florida 32216
Endo Res Solutions Inc Roswell Georgia 30076
East West Med Res Inst Honolulu Hawaii 96814
Evanston Premier Hlthcr Res Skokie Illinois 60077
Altasciences Clinical Kansas, Inc. Overland Park Kansas 66212
L-MARC Research Center Louisville Kentucky 40213
AMC Community Endocrinology Albany New York 12206
NYC Research, Inc. New York New York 10016
PharmQuest Life Sciences LLC Greensboro North Carolina 27408
Accellacare Wilmington North Carolina 28401
Medical Uni of SC Charleston Charleston South Carolina 29425
Coastal Carolina Res Ctr. North Charleston South Carolina 29405
Texas Diabetes & Endocrinology, P.A._Austin Austin Texas 78749
Soltero Cardiovascular Research Center Dallas Texas 75226
Texas Diabetes & Endocrinology, P.A._Austin Round Rock Texas 78681
Chrysalis Clinical Research St. George Utah 84790
Washington Cntr Weight Mgmt Arlington Virginia 22206
Health Res of Hampton Roads Newport News Virginia 23606
National Clin Res Inc. Richmond Virginia 23294
Selma Medical Associates Winchester Virginia 22601-3834

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04969939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2026 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04969939 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →